Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2008 | 1 |
2009 | 1 |
2021 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
External validation of the CRAX2MACE model in an Italian cohort of patients with suspected coronary artery disease undergoing stress myocardial perfusion imaging.
J Nucl Cardiol. 2022 Dec;29(6):2967-2973. doi: 10.1007/s12350-021-02855-9. Epub 2021 Nov 3.
J Nucl Cardiol. 2022.
PMID: 34734366
RESULTS: Considering the occurrence of MACE (death from any cause, acute myocardial infarction, or late coronary revascularization), for the CRAX2MACE model the area under the receiver operating characteristic curve was 0.612 and the Brier score was 0.061. The Hosmer-Lemeshow tes …
RESULTS: Considering the occurrence of MACE (death from any cause, acute myocardial infarction, or late coronary revascularization), for the …
Complications of laser ablation for hepatocellular carcinoma: a multicenter study.
Arienti V, Pretolani S, Pacella CM, Magnolfi F, Caspani B, Francica G, Megna AS, Regine R, Sponza M, Antico E, Di Lascio FM.
Arienti V, et al.
Radiology. 2008 Mar;246(3):947-55. doi: 10.1148/radiol.2463070390. Epub 2008 Jan 14.
Radiology. 2008.
PMID: 18195382
Postprocedural complications were related to clinical or percutaneous LA factors by using the Student t and chi(2) tests. Follow-up was carried out with computed tomography (CT) at 1, 3, 6, 9, and 12 months, and primary effectiveness rate was defined as the percentage of H …
Postprocedural complications were related to clinical or percutaneous LA factors by using the Student t and chi(2) tests. Follow-up w …
Item in Clipboard
Definition of progression risk based on combinations of cellular and molecular markers in patients with Binet stage A chronic lymphocytic leukaemia.
Morabito F, Cutrona G, Gentile M, Matis S, Todoerti K, Colombo M, Sonaglio C, Fabris S, Reverberi D, Megna M, Spriano M, Lucia E, Rossi E, Callea V, Mazzone C, Festini G, Zupo S, Molica S, Neri A, Ferrarini M.
Morabito F, et al.
Br J Haematol. 2009 Jun;146(1):44-53. doi: 10.1111/j.1365-2141.2009.07703.x. Epub 2009 May 6.
Br J Haematol. 2009.
PMID: 19438486
Free article.
The probability of being treatment-free at 3 years was significantly shorter in patients with unmutated IGHV genes (IGHVunmut 66% vs. 93%, chi square of log-rank = 30, P < 0.0001), ZAP-70 positive (ZAP-70pos 73% vs. 96%, chi square of log-rank = 8.2, P = 0.004) o
…
The probability of being treatment-free at 3 years was significantly shorter in patients with unmutated IGHV genes (IGHVunmut 66% vs. 93%, …
Item in Clipboard
Cite
Cite